Clinical Trial

Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF

Study acronym: ExplAIn-HF
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are: 1. To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms. 2. To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS). Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.
Protocol Amendment History 1 change
critical Enrolling by invitation only 2026-08-04
Trial Details
NCT Number NCT07689760
Lead Sponsor Medisch Spectrum Twente
Collaborators: Saxion University of Applied Sciences, Deventer Ziekenhuis, University of Twente, Ziekenhuisgroep Twente
Conditions Heart Failure
Enrollment 95 participants
Start Date 2026-07
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-03